05/22/2026
What an incredible experience at ATS/RIS 2026.
We were proud to be selected to present SMSbiotech’s clinical-stage Small Mobile Stem (SMS) cell platform among many of the leading innovators shaping the future of respiratory medicine.
From our Oral Showcase presentation to the many conversations shared throughout the conference, ATS/RIS 2026 was an exciting opportunity to connect with clinicians, researchers, partners, and investors from across the respiratory and biotechnology communities.
Thank you to everyone who stopped by, attended our presentation, connected with our team, or shared in the discussions around the future of regenerative medicine and chronic lung disease research.
We’re excited about the momentum ahead and grateful to be part of this important global conversation.